BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20226902)

  • 1. Xanthohumol inhibits the neuroendocrine transcription factor achaete-scute complex-like 1, suppresses proliferation, and induces phosphorylated ERK1/2 in medullary thyroid cancer.
    Cook MR; Luo J; Ndiaye M; Chen H; Kunnimalaiyaan M
    Am J Surg; 2010 Mar; 199(3):315-8; discussion 318. PubMed ID: 20226902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells.
    Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
    J Biol Chem; 2006 Dec; 281(52):39819-30. PubMed ID: 17090547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002.
    Kunnimalaiyaan M; Ndiaye M; Chen H
    Surgery; 2006 Dec; 140(6):1009-14; discussion 1014-5. PubMed ID: 17188151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer.
    Truong M; Cook MR; Pinchot SN; Kunnimalaiyaan M; Chen H
    Ann Surg Oncol; 2011 May; 18(5):1506-11. PubMed ID: 21184191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of human achaete-scute homolog-1 in medullary thyroid cancer cells.
    Sippel RS; Carpenter JE; Kunnimalaiyaan M; Chen H
    Surgery; 2003 Dec; 134(6):866-71; discussion 871-3. PubMed ID: 14668716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of medullary thyroid cancer by C-Raf-1 silences expression of the neural transcription factor human achaete-scute homolog-1.
    Chen H; Carson-Walter EB; Baylin SB; Nelkin BD; Ball DW
    Surgery; 1996 Aug; 120(2):168-72; discussion 173. PubMed ID: 8751579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xanthohumol decreases Notch1 expression and cell growth by cell cycle arrest and induction of apoptosis in epithelial ovarian cancer cell lines.
    Drenzek JG; Seiler NL; Jaskula-Sztul R; Rausch MM; Rose SL
    Gynecol Oncol; 2011 Aug; 122(2):396-401. PubMed ID: 21616523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.
    Ning L; Jaskula-Sztul R; Kunnimalaiyaan M; Chen H
    Ann Surg Oncol; 2008 Sep; 15(9):2600-5. PubMed ID: 18563491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary thyroid cancer: the functions of raf-1 and human achaete-scute homologue-1.
    Chen H; Kunnimalaiyaan M; Van Gompel JJ
    Thyroid; 2005 Jun; 15(6):511-21. PubMed ID: 16029117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chrysin suppresses achaete-scute complex-like 1 and alters the neuroendocrine phenotype of carcinoids.
    Somnay YR; Dull BZ; Eide J; Jaskula-Sztul R; Chen H
    Cancer Gene Ther; 2015 Oct; 22(10):496-505. PubMed ID: 26403073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MK-2206 causes growth suppression and reduces neuroendocrine tumor marker production in medullary thyroid cancer through Akt inhibition.
    Burke JF; Schlosser L; Harrison AD; Kunnimalaiyaan M; Chen H
    Ann Surg Oncol; 2013 Nov; 20(12):3862-8. PubMed ID: 23900743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of pasireotide and teriflunomide in carcinoids in vitro.
    Somnay Y; Chen H; Kunnimalaiyaan M
    Neuroendocrinology; 2013; 97(2):183-92. PubMed ID: 22965070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leflunomide suppresses growth in human medullary thyroid cancer cells.
    Alhefdhi A; Burke JF; Redlich A; Kunnimalaiyaan M; Chen H
    J Surg Res; 2013 Nov; 185(1):212-6. PubMed ID: 23816245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer effect of xanthohumol induces growth inhibition and apoptosis of human liver cancer through NF-κB/p53-apoptosis signaling pathway.
    Zhao X; Jiang K; Liang B; Huang X
    Oncol Rep; 2016 Feb; 35(2):669-75. PubMed ID: 26718026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch in the development of thyroid C-cells and the treatment of medullary thyroid cancer.
    Cook M; Yu XM; Chen H
    Am J Transl Res; 2010 Feb; 2(1):119-25. PubMed ID: 20182588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZM336372, a Raf-1 activator, inhibits growth of pheochromocytoma cells.
    Kappes A; Vaccaro A; Kunnimalaiyaan M; Chen H
    J Surg Res; 2006 Jun; 133(1):42-5. PubMed ID: 16603190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.
    Ning L; Greenblatt DY; Kunnimalaiyaan M; Chen H
    Oncologist; 2008 Feb; 13(2):98-104. PubMed ID: 18305053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line.
    Tesfazghi S; Eide J; Dammalapati A; Korlesky C; Wyche TP; Bugni TS; Chen H; Jaskula-Sztul R
    Cancer Med; 2013 Oct; 2(5):734-43. PubMed ID: 24403239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype.
    Chen JY; Cook MR; Pinchot SN; Kunnimalaiyaan M; Chen H
    J Surg Res; 2010 Jan; 158(1):15-9. PubMed ID: 19765735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xanthohumol inhibits cell cycle progression and proliferation of larynx cancer cells in vitro.
    Sławińska-Brych A; Król SK; Dmoszyńska-Graniczka M; Zdzisińska B; Stepulak A; Gagoś M
    Chem Biol Interact; 2015 Oct; 240():110-8. PubMed ID: 26297991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.